BioAge Labs Increases Proposed IPO to 10.5 Million Shares Priced Between $17 and $19 Each

BioAge Labs has submitted a request for an increased initial public offering (IPO) of 10,500,000 shares, priced between $17 and $19 each. Previously, the company had announced a 7.5 million share offering within the same price range.